{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T20:06:13Z","timestamp":1768680373355,"version":"3.49.0"},"reference-count":76,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2012,10,25]],"date-time":"2012-10-25T00:00:00Z","timestamp":1351123200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1002750","type":"journal-article","created":{"date-parts":[[2012,10,25]],"date-time":"2012-10-25T21:34:05Z","timestamp":1351200845000},"page":"e1002750","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":106,"title":["Integrating Cellular Metabolism into a Multiscale Whole-Body Model"],"prefix":"10.1371","volume":"8","author":[{"given":"Markus","family":"Krauss","sequence":"first","affiliation":[]},{"given":"Stephan","family":"Schaller","sequence":"additional","affiliation":[]},{"given":"Steffen","family":"Borchers","sequence":"additional","affiliation":[]},{"given":"Rolf","family":"Findeisen","sequence":"additional","affiliation":[]},{"given":"J\u00f6rg","family":"Lippert","sequence":"additional","affiliation":[]},{"given":"Lars","family":"Kuepfer","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2012,10,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nbt823","article-title":"High-throughput classification of yeast mutants for functional genomics using metabolic footprinting","volume":"21","author":"J Allen","year":"2003","journal-title":"Nat Biotechnol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e1000692","DOI":"10.1371\/journal.pcbi.1000692","article-title":"Interpreting metabolomic profiles using unbiased pathway models","volume":"6","author":"RC Deo","year":"2010","journal-title":"PLoS Comput Biol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nrg1880","article-title":"Inborn errors of metabolism: the flux from Mendelian to complex diseases","volume":"7","author":"B Lanpher","year":"2006","journal-title":"Nat Rev Genet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/msb.2010.56","article-title":"Computational reconstruction of tissue-specific metabolic models: application to human liver metabolism","volume":"6","author":"L Jerby","year":"2010","journal-title":"Mol Syst Biol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1073\/pnas.0610772104","article-title":"Global reconstruction of the human metabolic network based on genomic and bibliomic data","volume":"104","author":"NC Duarte","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/msb.2010.70","article-title":"Towards whole-body systems physiology","volume":"6","author":"L Kuepfer","year":"2010","journal-title":"Mol Syst Biol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/1752-0509-5-180","article-title":"A multi-tissue type genome-scale metabolic network for analysis of whole-body systems physiology","volume":"5","author":"A Bordbar","year":"2011","journal-title":"BMC Syst Biol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"10371","DOI":"10.1073\/pnas.0909374107","article-title":"Prediction and validation of cell alignment along microvessels as order principle to restore tissue architecture in liver regeneration","volume":"107","author":"S Hoehme","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/978-1-4419-7210-1_32","article-title":"Multiscale Mechanistic Modeling in Pharmaceutical Research and Development","volume":"736","author":"L Kuepfer","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1517\/17425255.3.2.235","article-title":"Whole-body physiologically based pharmacokinetic models","volume":"3","author":"I Nestorov","year":"2007","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1478-5382(03)02342-4","article-title":"PK-Sim\u00ae: a physiologically based pharmacokinetic \u2018whole-body\u2019 model","volume":"1","author":"S Willmann","year":"2003","journal-title":"Biosilico"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ddtec.2004.09.006","article-title":"Physiology-based pharmacokinetic modeling: ready to be used","volume":"1","author":"W Schmitt","year":"2004","journal-title":"Drug Discov Today: Technologies"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev-pharmtox-010510-100540","article-title":"Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science","volume":"51","author":"M Rowland","year":"2011","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref14","first-page":"401","article-title":"Basic concepts of pharmacokinetic\/pharmacodynamic (PK\/PD) modelling","volume":"35","author":"B Meibohm","year":"1997","journal-title":"Int J Clin Pharm Th"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/jps.20322","article-title":"Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases","volume":"94","author":"T Rodgers","year":"2005","journal-title":"J Pharm Sci"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/jps.20502","article-title":"Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions","volume":"95","author":"T Rodgers","year":"2006","journal-title":"J Pharm Sci"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/1520-6017(200104)90:4<436::AID-JPS1002>3.0.CO;2-P","article-title":"Prediction of adipose tissue: plasma partition coefficients for structurally unrelated drugs","volume":"90","author":"P Poulin","year":"2001","journal-title":"J Pharm Sci"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1023\/B:PHAM.0000003373.72652.c0","article-title":"A physiologic model for simulating gastrointestinal flow and drug absorption in rats","volume":"20","author":"S Willmann","year":"2003","journal-title":"Pharm Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1021\/jm030999b","article-title":"A physiological model for the estimation of the fraction dose absorbed in humans","volume":"47","author":"S Willmann","year":"2004","journal-title":"J Med Chem"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1124\/dmd.111.043174","article-title":"Using expression data for quantification of active processes in physiologically-based pharmacokinetic modeling","volume":"40","author":"M Meyer","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF03256429","article-title":"Pharmacogenomics of Codeine, Morphine, and Morphine-6-Glucuronide: Model-Based Analysis of the Influence of CYP2D6 Activity, UGT2B7 Activity, Renal Impairment, and CYP3A4 Inhibition","volume":"16","author":"T Eissing","year":"2012","journal-title":"Mol Diagn Ther"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2125.2011.04064.x","article-title":"Prediction of a potentially effective dose in humans for BAY 60-5521, a potent inhibitor of cholesteryl ester transfer protein (CETP) by allometric species scaling and combined pharmacodynamic and physiologically-based pharmacokinetic modelling","volume":"73","author":"O Weber","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/clpt.2009.151","article-title":"Risk to the breast-fed neonate from codeine treatment to the mother: a quantitative mechanistic modeling study","volume":"86","author":"S Willmann","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1073\/pnas.0610772104","article-title":"Global reconstruction of the human metabolic network based on genomic and bibliomic data","volume":"104","author":"NC Duarte","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.drudis.2008.02.002","article-title":"Human metabolic network reconstruction and its impact on drug discovery and development","volume":"13","author":"H Ma","year":"2008","journal-title":"Drug Discov Today"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/msb.2010.62","article-title":"HepatoNet1: a comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver physiology","volume":"6","author":"C Gille","year":"2010","journal-title":"Mol Syst Biol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1137\/040603127","article-title":"Understanding the Immune Response in Tuberculosis Using Different Mathematical Models and Biological Scales","volume":"3","author":"D Gammack","year":"2005","journal-title":"Multiscale Model Sim"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.compchemeng.2006.10.004","article-title":"Addressing the challenges of multiscale model management in systems biology","volume":"31","author":"J Hetherington","year":"2007","journal-title":"Comput Chem Eng"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1093\/bioinformatics\/btn352","article-title":"Integrating metabolic, transcriptional regulatory and signal transduction models in <italic>Escherichia coli<\/italic>","volume":"24","author":"MW Covert","year":"2008","journal-title":"Bioinformatics"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e1000086","DOI":"10.1371\/journal.pcbi.1000086","article-title":"Dynamic analysis of integrated signaling, metabolic, and regulatory networks","volume":"4","author":"JM Lee","year":"2008","journal-title":"PLoS Comput Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0006-3495(02)73903-9","article-title":"Dynamic flux balance analysis of diauxic growth in <italic>Escherichia coli<\/italic>","volume":"83","author":"R Mahadevan","year":"2002","journal-title":"Biophys J"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/msb.2009.22","article-title":"Predicting metabolic biomarkers of human inborn errors of metabolism","volume":"5","author":"T Shlomi","year":"2009","journal-title":"Mol Syst Biol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/sj.embor.embor944","article-title":"Parallel analysis of transcript and metabolic profiles: a new approach in systems biology","volume":"4","author":"E Urbanczyk-Wochniak","year":"2003","journal-title":"EMBO Rep"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/jps.2600721003","article-title":"Physiologically based pharmacokinetic modeling: principles and applications","volume":"72","author":"LE Gerlowski","year":"1983","journal-title":"J Pharm Sci"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/nrmicro1023","article-title":"Genome-scale models of microbial cells: evaluating the consequences of constraints","volume":"2","author":"ND Price","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.tibtech.2004.07.007","article-title":"Bow ties, metabolism and disease","volume":"22","author":"M Csete","year":"2004","journal-title":"Trends Biotechnol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1093\/bioinformatics\/btg177","article-title":"The connectivity structure, giant strong component and centrality of metabolic networks","volume":"19","author":"HW Ma","year":"2003","journal-title":"Bioinformatics"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/msb4100177","article-title":"The Edinburgh human metabolic network reconstruction and its functional analysis","volume":"3","author":"H Ma","year":"2007","journal-title":"Mol Syst Biol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0006-2952(99)00341-X","article-title":"Purinergic and pyrimidinergic receptors as potential drug targets","volume":"59","author":"M Williams","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"ref40","unstructured":"Thews G, Mutschler E, Vaupel P (1999) Anatomie, Physiologie, Pathophysiologie des Menschen. Stuttgart: Wissenschaftliche Verlagsgesellschaft. 868 p."},{"key":"ref41","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1124\/pr.58.1.6","article-title":"Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol","volume":"58","author":"P Pacher","year":"2006","journal-title":"Pharmacol Rev"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0891-5849(02)00956-5","article-title":"Structure and function of xanthine oxidoreductase: where are we now?","volume":"33","author":"R Harrison","year":"2002","journal-title":"Free Radic Biol Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2125.1999.00041.x","article-title":"Pharmacokinetics and pharmacodynamics of allopurinol in elderly and young subjects","volume":"48","author":"K Turnheim","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"ref44","unstructured":"Becker MA (1995) Hyperuricemia and gout. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. 7 ed. New York: McGraw-Hill. pp. 1192."},{"key":"ref45","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/cbdv.200890059","article-title":"Synthesis of resveratrol analogues, and evaluation of their cytotoxic and xanthine oxidase inhibitory activities","volume":"5","author":"XF Huang","year":"2008","journal-title":"Chem Biodivers"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s002280050569","article-title":"Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activities","volume":"54","author":"P Fuchs","year":"1999","journal-title":"Eur J Clin Pharmacol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Y Cheng","year":"1973","journal-title":"Biochem Pharmacol"},{"key":"ref48","unstructured":"Lentner C, editor (1981) Geigy Scientific Tables. West Cadwell, N.J."},{"key":"ref49","doi-asserted-by":"crossref","first-page":"D603","DOI":"10.1093\/nar\/gkn810","article-title":"HMDB: a knowledgebase for the human metabolome","volume":"37","author":"DS Wishart","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1046\/j.1471-4159.1996.67041584.x","article-title":"Severity of hyperammonemic encephalopathy correlates with brain ammonia level and saturation of glutamine synthetase in vivo","volume":"67","author":"K Kanamori","year":"1996","journal-title":"J Neurochem"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0002-9343(02)01477-8","article-title":"Correlation between ammonia levels and the severity of hepatic encephalopathy","volume":"114","author":"JP Ong","year":"2003","journal-title":"Am J Med"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1023\/B:MEBR.0000043980.74574.eb","article-title":"Blood ammonia levels and hepatic encephalopathy","volume":"19","author":"AH Lockwood","year":"2004","journal-title":"Metab Brain Dis"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11940-003-0037-5","article-title":"Urea Cycle Disorders","volume":"5","author":"S Kleppe","year":"2003","journal-title":"Curr Treat Options Neurol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1475-097X.1985.tb00753.x","article-title":"Ammonia metabolism during exercise in man","volume":"5","author":"LS Eriksson","year":"1985","journal-title":"Clin Physiol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/sj.jcbfm.9600168","article-title":"Persistent arterial hyperammonemia increases the concentration of glutamine and alanine in the brain and correlates with intracranial pressure in patients with fulminant hepatic failure","volume":"26","author":"F Tofteng","year":"2006","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jhep.2009.11.014","article-title":"Adult-onset ornithine transcarbamylase (OTC) deficiency unmasked by the Atkins&apos; diet","volume":"52","author":"Z Ben-Ari","year":"2010","journal-title":"J Hepatol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0022-3476(05)81200-4","article-title":"Plasma glutamine concentration: a guide in the management of urea cycle disorders","volume":"121","author":"NE Maestri","year":"1992","journal-title":"J Pediatr"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10928-007-9053-5","article-title":"Development of a physiology-based whole-body population model for assessing the influence of individual variability on the pharmacokinetics of drugs","volume":"34","author":"S Willmann","year":"2007","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejpb.2010.06.003","article-title":"Mechanism-based prediction of particle size-dependent dissolution and absorption: cilostazol pharmacokinetics in dogs","volume":"76","author":"S Willmann","year":"2010","journal-title":"Eur J Pharm Biopharm"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/hep.20948","article-title":"Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study","volume":"42","author":"AM Larson","year":"2005","journal-title":"Hepatology"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1056\/NEJMct0708278","article-title":"Acetylcysteine for acetaminophen poisoning","volume":"359","author":"KJ Heard","year":"2008","journal-title":"N Engl J Med"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1096\/fj.07-8506com","article-title":"Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man","volume":"22","author":"B Hinz","year":"2008","journal-title":"FASEB J"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/978-3-642-00663-0_12","article-title":"Mechanisms of acetaminophen-induced liver necrosis","author":"JA Hinson","year":"2010","journal-title":"Handb Exp Pharmacol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3109\/03602539208996298","article-title":"Molecular aspects of paracetamol-induced hepatotoxicity and its mechanism-based prevention","volume":"24","author":"NP Vermeulen","year":"1992","journal-title":"Drug Metab Rev"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1248\/bpb.30.157","article-title":"Pharmacokinetics\/pharmacodynamics of acetaminophen analgesia in Japanese patients with chronic pain","volume":"30","author":"S Shinoda","year":"2007","journal-title":"Biol Pharm Bull"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1081\/DMR-200033494","article-title":"Acetaminophen-induced hepatotoxicity: role of metabolic activation, reactive oxygen\/nitrogen species, and mitochondrial permeability transition","volume":"36","author":"JA Hinson","year":"2004","journal-title":"Drug Metab Rev"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1049\/sb:20045004","article-title":"Analysis of structural robustness of metabolic networks","volume":"1","author":"T Wilhelm","year":"2004","journal-title":"Systems Biol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1186\/gb-2005-6-6-r49","article-title":"Large-scale 13C-flux analysis reveals mechanistic principles of metabolic network robustness to null mutations in yeast","volume":"6","author":"LM Blank","year":"2005","journal-title":"Genome Biol"},{"key":"ref69","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2011.00004","article-title":"A computational systems biology software platform for multiscale modeling and simulation: integrating whole-body physiology, disease biology, and molecular reaction networks","volume":"2","author":"T Eissing","year":"2011","journal-title":"Front Physio"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrd2033","article-title":"Diagnostics and biomarker development: priming the pipeline","volume":"5","author":"KA Phillips","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"ref71","doi-asserted-by":"crossref","DOI":"10.1038\/msb4100162","article-title":"Systematic evaluation of objective functions for predicting intracellular fluxes in <italic>Escherichia coli<\/italic>","volume":"3","author":"R Schuetz","year":"2007","journal-title":"Mol Syst Biol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jtbi.2004.02.006","article-title":"Monte Carlo sampling can be used to determine the size and shape of the steady-state flux space","volume":"228","author":"SJ Wiback","year":"2004","journal-title":"J Theor Biol"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/nbt.1487","article-title":"Network-based prediction of human tissue-specific metabolism","volume":"26","author":"T Shlomi","year":"2008","journal-title":"Nat Biotechnol"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature02456","article-title":"Integrating high-throughput and computational data elucidates bacterial networks","volume":"429","author":"MW Covert","year":"2004","journal-title":"Nature"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00253-010-2506-6","article-title":"Metabolic flux distributions: genetic information, computational predictions, and experimental validation","volume":"86","author":"LM Blank","year":"2010","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0167-7799(03)00030-1","article-title":"Genome-scale microbial in silico models: the constraints-based approach","volume":"21","author":"ND Price","year":"2003","journal-title":"Trends Biotechnol"}],"container-title":["PLoS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1002750","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T04:18:45Z","timestamp":1594786725000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1002750"}},"subtitle":[],"editor":[{"given":"Jason A.","family":"Papin","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2012,10,25]]},"references-count":76,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2012,10,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1002750","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,25]]}}}